Determination of ivermectin in plasma and whole blood using LC-MS/MS
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
A high-throughput LC-MS/MS assay for piperaquine from dried blood spots: Improving malaria treatment in resource-limited settings.
Blessborn D. et al, (2024), Journal of mass spectrometry and advances in the clinical lab, 31, 19 - 26
Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry
Wongchang T. et al, (2022), Wellcome Open Research, 4, 47 - 47
Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry
Wongchang T. et al, (2021), Wellcome Open Research, 4, 47 - 47
Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.
Groger M. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry
Wongchang T. et al, (2019), Wellcome Open Research, 4, 47 - 47
High sensitivity methods to quantify chloroquine and its metabolite in human blood samples using LC–MS/MS
Kaewkhao K. et al, (2019), Bioanalysis, 11, 333 - 347
Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
Chairat K. et al, (2018), Journal of Antimicrobial Chemotherapy, 73, 3102 - 3113
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin–piperaquine in healthy volunteers
Chotsiri P. et al, (2017), British Journal of Clinical Pharmacology, 83, 2752 - 2766
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF LUMEFANTRINE IN YOUNG UGANDAN CHILDREN TREATED IN COMBINATION WITH ARTEMETHER FOR UNCOMPLICATED MALARIA
Tchaparian E. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 95, 465 - 465
Quantification of the antimalarial drug pyronaridine in whole blood using LC–MS/MS — Increased sensitivity resulting from reduced non-specific binding
Blessborn D. et al, (2017), Journal of Pharmaceutical and Biomedical Analysis, 146, 214 - 219
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
Tchaparian E. et al, (2016), Journal of Infectious Diseases, 214, 1243 - 1251
Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Amaratunga C. et al, (2016), The Lancet Infectious Diseases, 16, 357 - 365
Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border
Kloprogge F. et al, (2015), Antimicrobial Agents and Chemotherapy, 59, 6375 - 6384
Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
Jittamala P. et al, (2015), Antimicrobial Agents and Chemotherapy, 59, 505 - 513
Chloroquine Is Grossly Under Dosed in Young Children with Malaria: Implications for Drug Resistance
Ursing J. et al, (2014), PLoS ONE, 9, e86801 - e86801
Comparison of Oseltamivir and Oseltamivir Carboxylate Concentrations in Venous Plasma, Venous Blood, and Capillary Blood in Healthy Volunteers
Instiaty I. et al, (2013), Antimicrobial Agents and Chemotherapy, 57, 2858 - 2862
Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds
Blessborn D. et al, (2013), Bioanalysis, 5, 31 - 39
Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Ngasala BE. et al, (2011), Clinical Infectious Diseases, 52, 873 - 882